AMX0035 and Progressive Supranuclear Palsy

Conditions: Progressive Supranuclear Palsy; PSP; Neurodegenerative Diseases; Atypical Parkinsonism Interventions: Drug: AMX0035; Other: Placebo Sponsors: Amylyx Pharmaceuticals Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06122662

Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials

More News: Brain | Neurology | Progressive Supranuclear Palsy | Research